FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 60505-3276 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA091265
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (10 mg/1)
Marketing started20111024
Package count3

External sources

Source: openFDA. Public-domain (CC0).